A mRNA panel for differentiation between acute exacerbation or pneumonia in COPD patients

A mRNA panel for differentiation between acute exacerbation or pneumonia in COPD patients

IntroductionPatients suffering from chronic obstructive pulmonary disease (COPD) are prone to acute exacerbations (AECOPD) or community acquired pneumonia (CAP), both posing severe risk of morbidity and mortality. There is no available biomarker that correctly separates AECOPD from COPD. However, be...

Full description

Bibliographic Details
Main Authors: Wilhelm Bertrams, Jochen Wilhelm, Pia-Marie Veeger, Carolina Hanko, Kristina auf dem Brinke, Björn Klabunde, Hendrik Pott, Barbara Weckler, Timm Greulich, Claus F. Vogelmeier, Bernd Schmeck
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-03-01
Series:Frontiers in Medicine
Subjects:
pneumonia
COPD exacerbation
comorbidity
transcriptome
COPD
Online Access:https://www.frontiersin.org/articles/10.3389/fmed.2024.1234068/full

Internet

https://www.frontiersin.org/articles/10.3389/fmed.2024.1234068/full

Similar Items